Clinton Larry Stinchcomb, the President and CEO of $CURI, sold 252,486 shares of the company on 06-13-2025 for an estimated $1,181,053. We received data on the trade from a recent SEC filing. This was a sale of approximately 10.8% of their shares of this class of stock. Following this trade, they now own 2,085,827 shares of this class of $CURI stock.
$CURI Insider Trading Activity
$CURI insiders have traded $CURI stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $CURI stock by insiders over the last 6 months:
- JOHN S HENDRICKS has made 0 purchases and 7 sales selling 600,000 shares for an estimated $3,087,521.
- CLINTON LARRY STINCHCOMB (President and CEO) has made 0 purchases and 2 sales selling 332,486 shares for an estimated $1,556,733.
- PHILLIP BRADY HAYDEN (Chief Financial Officer) sold 1,000 shares for an estimated $4,890
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CURI Hedge Fund Activity
We have seen 35 institutional investors add shares of $CURI stock to their portfolio, and 19 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC added 366,941 shares (+661.0%) to their portfolio in Q1 2025, for an estimated $983,401
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 247,700 shares (+155.9%) to their portfolio in Q1 2025, for an estimated $663,836
- PENN MUTUAL ASSET MANAGEMENT added 245,289 shares (+inf%) to their portfolio in Q1 2025, for an estimated $657,374
- JANE STREET GROUP, LLC added 181,405 shares (+inf%) to their portfolio in Q1 2025, for an estimated $486,165
- MANATUCK HILL PARTNERS, LLC removed 146,078 shares (-26.6%) from their portfolio in Q1 2025, for an estimated $391,489
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 142,911 shares (+inf%) to their portfolio in Q1 2025, for an estimated $383,001
- GOLDMAN SACHS GROUP INC added 109,138 shares (+657.3%) to their portfolio in Q1 2025, for an estimated $292,489
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CURI Analyst Ratings
Wall Street analysts have issued reports on $CURI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 05/07/2025
To track analyst ratings and price targets for $CURI, check out Quiver Quantitative's $CURI forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
